A new study published on March 5, 2025, in the New England Journal of Medicine is making waves by suggesting that treating male partners with antibiotics may help prevent BV recurrence. In response, the internet is running wild with claims that BV is a sexually transmitted infection (STI).
But here’s the thing—while the study brings up interesting findings, the way it's being framed is misleading. BV is not an STI. It’s a condition of microbial imbalance in the vagina, not a straightforward infection passed between partners. The real issue isn’t the presence of BV-associated bacteria—it’s whether the vaginal microbiome is resilient enough to regulate itself.
Here’s why we need a major shift in how we talk about and treat BV.
1. The Real Problem: A Weakened Vaginal Microbiome, Not Just Exposure to Bacteria
The idea that men are "giving" women BV the way they might with chlamydia or gonorrhea misunderstands how the vaginal ecosystem works.
Your vagina is not sterile—it’s an ecosystem of both good and bad bacteria. What keeps it healthy is having more “good guys” (Lactobacillus species) than “bad guys” (BV-associated bacteria like Gardnerella vaginalis and Prevotella).
When your Lactobacillus levels drop—whether due to hormonal changes, antibiotics, douching, or other disruptions—the vaginal pH rises, creating an environment where bad bacteria can overgrow. That’s when BV symptoms like odor, discharge, and irritation start.
🔬 What the Research Says:
A study in The Journal of Infectious Diseases found G. vaginalis in 87% of women without BV, proving that its presence alone does not cause BV.
Research in Frontiers in Cellular and Infection Microbiology confirmed that BV-associated bacteria can exist in healthy, asymptomatic women.
This means BV isn’t about simply coming into contact with bacteria—it’s about whether your vaginal microbiome is strong enough to regulate itself.
2. Treating Men Doesn’t Solve the Real Issue
Yes, BV-associated bacteria can be found on male genitalia. But does that mean men are the source of BV? No.
The recent study examined whether treating male partners with antibiotics could reduce BV recurrence in women. While the results showed some reduction in recurrence, it didn’t entirely fix the problem. Why? Because even if you eliminate BV-associated bacteria from both partners, if the vaginal microbiome isn’t restored, BV is likely to return.
Imagine constantly getting sick because your immune system is weak—treating the sickness without strengthening your immunity doesn’t prevent future illness. The same logic applies to the vaginal microbiome. If good bacteria aren’t replenished, BV will keep coming back.
🔬 What the Research Says:
A study in mBio found that Lactobacillus crispatus enhances the trapping of HIV-1 in vaginal mucus, reducing infection risk.
Research in The Journal of Infectious Diseases showed that hydrogen peroxide-producing Lactobacillus species lower STI risk.
So instead of just wiping out bacteria, we should focus on strengthening the vaginal microbiome with probiotics and microbiome-supportive interventions.
3. The Problem with Antibiotic-Only Treatments
The medical system has been stuck in an outdated model for too long—treating BV like a typical bacterial infection, where the goal is to kill bacteria instead of restoring balance.
This is why 50-60% of women experience BV recurrence within a year of antibiotic treatment. Antibiotics don’t just wipe out BV-associated bacteria—they also kill the good bacteria (Lactobacillus) needed to prevent BV in the first place.
This would be like overusing acne treatments that strip the skin’s protective barrier, making it more vulnerable to breakouts. Or taking antibiotics too often and destroying gut bacteria, leading to digestive issues. The vagina works the same way.
What the Research Says:
A study published in Nature Reviews Microbiology highlights that BV is an imbalance, not a traditional infection.
Research in The Lancet Infectious Diseases found that over half of women experience BV recurrence after antibiotic treatment, showing the need for long-term microbiome-focused interventions.
Instead of short-term fixes, we need to support the vaginal ecosystem in rebuilding its natural defenses.
4. The Future of BV Management: Restoring, Not Just Eliminating
If this new study has shown us anything, it’s that BV is not an STI, but that our treatment approach is outdated. The real conversation should be about restoring and maintaining a resilient vaginal microbiome.
What Needs to Change:
Shift the focus from "killing bacteria" to "strengthening good bacteria.
Support microbiome health with probiotics, not just antibiotics.
Educate on how to maintain a balanced vaginal ecosystem.
Develop long-term interventions like vaginal microbiota transplants (VMT).
Women deserve better solutions—ones that go beyond short-term symptom relief and instead create a thriving vaginal microbiome that prevents BV from recurring.
BV is not an STI. It’s a microbiome imbalance—one that requires a smarter, science-backed approach to treatment.
Instead of waging war on bacteria, we need to support the vaginal microbiome in restoring balance. Because the stronger the “good guys” (Lactobacillus), the better protected your vaginal health will be.
It’s time to change the conversation.
Comments